Sharp re-rating has turned the stock into the most expensive in the pharma space
Higher earnings growth, lower costs, and valuations favour smaller companies
Company attributes achievement to sharp focus on motorcycles, strategies of differentiation and practice of TPM combined with global ambitions
Analysts have revised their growth guidance for FY22
Valuations, however, are factoring in near-term benefits of growth and consolidation
Price hikes to offset some of the the surge in raw material costs
Valuations, however, are factoring near term gains
Muted near term cash flows, increase in debt and valuations to cap upside
Cost reduction, higher private label sales to aid margins
Valuations, however, discount near-term gains on revenue visibility, execution
Valuations factor in the volume rebound, leaving little upside from the current levels
Macquarie Capital expects Dish TV, a Zee subsidiary, to report a Rs 300 crore free cash flow in FY21
The company is expected to gain market share led by higher tonnage trucks
Rise in costs, lower realisations could keep profitability under pressure
Margin gains in the September quarter too are expected to continue
The recent trigger for the stock was a better-than-expected operating performance in the September quarter.
Rebound in oil and gas vertical, passenger vehicle volume growth are other triggers
Higher in-home consumption and premiumisation to benefit the Diageo-owned company
Momentum in existing products, market share gains are other triggers
Volume recovery and cost rationalisation may offset some of the pressure on margins